Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
Verlagsversion
DOI
PMC
 |
Open Access Gold |
|
möglich sobald bei der ZB eingereicht worden ist.
Emerging targets in type 2 diabetes and diabetic complications.
Adv. Sci., e2100275 (2021)
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Insulin Resistance ; Metabolism ; Signaling Pathways ; Type 2 Diabetes, Diabetic Complications; Magnetic-resonance Neurography; Improves Insulin Sensitivity; Intensive Glucose Control; Beta-cell Dysfunction; Kidney-disease; Microvascular Complications; Metabolic Memory; Adipose-tissue; In-vivo; Multifactorial Intervention
ISSN (print) / ISBN
2198-3844
e-ISSN
2198-3844
Zeitschrift
Advanced science
Quellenangaben
Seiten: e2100275
Verlag
Wiley
Verlagsort
Weinheim
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Diabetes and Cancer (IDC)
Förderungen
German Research Foundation (DFG)
Collaboration Research Center (CRC)
Collaboration Research Center (CRC)